Clonal expansion and somatic hypermutations of CSF B cell repertoires are consistent features that have already been reported in early MS studies [52,53,57,68,69,70,71,72] and did not include a sufficient analysis of peripheral blood (PB) B cell repertoires. This evidence concerns the gene CSF2 and myeloid sarcoma.